Henry Schein, Inc.

  • Market Cap: Small Cap
  • Industry: Retailing
  • ISIN: US8064071025
USD
73.34
1.67 (2.33%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.12 M

Shareholding (Mar 2025)

FII

23.23%

Held by 291 FIIs

DII

22.91%

Held by 62 DIIs

Promoter

9.69%

How big is Henry Schein, Inc.?

22-Jun-2025

As of Jun 18, Henry Schein, Inc. has a market capitalization of $8.54 billion, with net sales of $12.67 billion and a net profit of $413 million over the latest four quarters. The balance sheet shows shareholder's funds of $3.39 billion and total assets of $10.22 billion.

As of Jun 18, Henry Schein, Inc. has a market capitalization of 8,539.84 million, categorizing it as a Mid Cap company.<BR><BR>As of Jun 18, the company reported net sales of 12,669.00 million and a net profit of 413.00 million for the latest four quarters.<BR><BR>As of Dec 24, the balance sheet shows shareholder's funds of 3,393.00 million and total assets of 10,218.00 million.

Read More

What does Henry Schein, Inc. do?

22-Jun-2025

Henry Schein, Inc. is a healthcare products and services provider for dental and medical practitioners, with net sales of $3.168 billion and a market cap of $8.54 billion as of March 2025. Key metrics include a P/E ratio of 17.00 and a return on equity of 15.64%.

Overview:<BR>Henry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental and medical practitioners, operating in the retailing industry within the mid-cap market.<BR><BR>Financial Snapshot:<BR>- Net Sales: 3,168 Million (Quarterly Results - Mar 2025)<BR>- Net Profit: 113 Million (Quarterly Results - Mar 2025)<BR>- Market-cap: USD 8,539.84 Million (Mid Cap)<BR><BR>Key Metrics:<BR>- P/E: 17.00<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: 0.86<BR>- Return on Equity: 15.64%<BR>- Price to Book: 2.58<BR><BR>Contact Details:<BR>- Address: 135 Duryea Rd, MELVILLE NY: 11747<BR>- Tel: ['1 631 8435500', '1 631 3908105']<BR>- Fax: 1 302 6365454<BR>- Website: https://www.henryschein.com/

Read More

Should I buy, sell or hold Henry Schein, Inc.?

22-Jun-2025

Who are in the management team of Henry Schein, Inc.?

22-Jun-2025

As of March 2022, the management team of Henry Schein, Inc. includes Stanley Bergman (CEO), James Breslawski (President), Steven Paladino (CFO), Gerald Benjamin (CAO), and Mark Mlotek (CSO), along with a Board of Directors featuring Philip Laskawy as Lead Independent Director. This team is responsible for the company's strategic direction and operations.

As of March 2022, the management team of Henry Schein, Inc. includes the following key members:<BR><BR>- Mr. Stanley Bergman: Chairman of the Board, Chief Executive Officer<BR>- Mr. James Breslawski: President, Vice Chairman of the Board, Director<BR>- Mr. Steven Paladino: Chief Financial Officer, Executive Vice President, Director<BR>- Mr. Gerald Benjamin: Chief Administrative Officer, Executive Vice President, Director<BR>- Mr. Mark Mlotek: Chief Strategic Officer, Executive Vice President, Director<BR><BR>Additionally, the Board of Directors includes:<BR><BR>- Mr. Philip Laskawy: Lead Independent Director<BR>- Mr. Barry Alperin: Independent Director<BR>- Mr. Paul Brons: Independent Director<BR>- Ms. Shira Goodman: Independent Director<BR>- Mr. Joseph Herring: Independent Director<BR><BR>This team plays a crucial role in guiding the company's strategic direction and operations.

Read More

Is Henry Schein, Inc. technically bullish or bearish?

20-Sep-2025

As of September 12, 2025, Henry Schein, Inc. is in a bearish trend, indicated by negative MACD readings, bearish Bollinger Bands, and underperformance against the S&P 500, with year-to-date and one-year returns of -0.94% and -5.40%, respectively.

As of 12 September 2025, the technical trend for Henry Schein, Inc. has changed from mildly bearish to bearish. The current technical stance is bearish, with key indicators supporting this view including bearish MACD readings on both weekly and monthly time frames, bearish Bollinger Bands, and a bearish daily moving average. The KST is weekly bearish and monthly mildly bullish, while the Dow Theory indicates a mildly bullish stance on the weekly but no trend on the monthly. Additionally, the OBV is mildly bearish on both weekly and monthly time frames. <BR><BR>In terms of multi-period returns, Henry Schein has underperformed the S&P 500 across various time frames, notably with a year-to-date return of -0.94% compared to the S&P 500's 12.22%, and a one-year return of -5.40% versus the S&P 500's 17.14%.

Read More

Is Henry Schein, Inc. overvalued or undervalued?

25-Nov-2025

As of November 21, 2025, Henry Schein, Inc. has an attractive valuation with a P/E ratio of 17 and a PEG ratio of 0.88, indicating it is undervalued compared to peers, despite lagging behind the S&P 500 over the past 3 and 5 years.

As of 21 November 2025, the valuation grade for Henry Schein, Inc. has moved from fair to attractive, indicating a more favorable assessment of its value. The company appears to be undervalued based on its current metrics, with a P/E ratio of 17, a PEG ratio of 0.88, and an EV to EBITDA ratio of 10.66. In comparison, peers such as Patterson Cos., Inc. have a higher P/E ratio of 19.39, while Sally Beauty Holdings, Inc. shows a very attractive valuation with a P/E of 7.40.<BR><BR>Recent stock performance shows that Henry Schein has outperformed the S&P 500 over the past week and month, with returns of 4.51% and 16.64%, respectively, while the S&P 500 experienced declines. However, over longer periods, such as the 3-year and 5-year marks, the company has lagged behind the S&P 500, with returns of -7.39% and 15.32%, respectively. Overall, Henry Schein's attractive valuation metrics suggest it is a compelling investment opportunity in the retailing sector.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

High Management Efficiency with a high ROCE of 15.35%

 
2

Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.57 times

 
3

Poor long term growth as Operating profit has grown by an annual rate 6.35% of over the last 5 years

 
4

Flat results in Jun 25

5

With ROCE of 12.57%, it has a fair valuation with a 1.85 Enterprise value to Capital Employed

6

Rising Promoter Confidence

7

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Retailing

stock-summary
Market cap

USD 8,215 Million (Small Cap)

stock-summary
P/E

17.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.86

stock-summary
Return on Equity

14.90%

stock-summary
Price to Book

2.38

Revenue and Profits:
Net Sales:
3,240 Million
(Quarterly Results - Jun 2025)
Net Profit:
94 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
9.25%
0%
9.25%
6 Months
3.93%
0%
3.93%
1 Year
-2.49%
0%
-2.49%
2 Years
5.46%
0%
5.46%
3 Years
-11.95%
0%
-11.95%
4 Years
3.06%
0%
3.06%
5 Years
10.34%
0%
10.34%

Henry Schein, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
6.57%
EBIT Growth (5y)
6.35%
EBIT to Interest (avg)
14.97
Debt to EBITDA (avg)
1.57
Net Debt to Equity (avg)
0.86
Sales to Capital Employed (avg)
2.15
Tax Ratio
24.67%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
15.35%
ROE (avg)
15.90%
Valuation key factors
Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
2.59
EV to EBIT
14.76
EV to EBITDA
10.66
EV to Capital Employed
1.85
EV to Sales
0.90
PEG Ratio
0.88
Dividend Yield
NA
ROCE (Latest)
12.57%
ROE (Latest)
15.64%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 115 Schemes (44.15%)

Foreign Institutions

Held by 291 Foreign Institutions (23.23%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 2.27% vs -0.72% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -16.81% vs 17.71% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,240.00",
          "val2": "3,168.00",
          "chgp": "2.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "251.00",
          "val2": "275.00",
          "chgp": "-8.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "38.00",
          "val2": "35.00",
          "chgp": "8.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-24.00",
          "val2": "-27.00",
          "chgp": "11.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "94.00",
          "val2": "113.00",
          "chgp": "-16.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "54.00%",
          "val2": "63.80%",
          "chgp": "-0.98%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 2.71% vs -2.44% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -8.72% vs -22.97% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "12,673.00",
          "val2": "12,339.00",
          "chgp": "2.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,026.00",
          "val2": "962.00",
          "chgp": "6.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "131.00",
          "val2": "87.00",
          "chgp": "50.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-120.00",
          "val2": "-126.00",
          "chgp": "4.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "398.00",
          "val2": "436.00",
          "chgp": "-8.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "57.50%",
          "val2": "57.90%",
          "chgp": "-0.04%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
3,240.00
3,168.00
2.27%
Operating Profit (PBDIT) excl Other Income
251.00
275.00
-8.73%
Interest
38.00
35.00
8.57%
Exceptional Items
-24.00
-27.00
11.11%
Consolidate Net Profit
94.00
113.00
-16.81%
Operating Profit Margin (Excl OI)
54.00%
63.80%
-0.98%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 2.27% vs -0.72% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -16.81% vs 17.71% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
12,673.00
12,339.00
2.71%
Operating Profit (PBDIT) excl Other Income
1,026.00
962.00
6.65%
Interest
131.00
87.00
50.57%
Exceptional Items
-120.00
-126.00
4.76%
Consolidate Net Profit
398.00
436.00
-8.72%
Operating Profit Margin (Excl OI)
57.50%
57.90%
-0.04%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 2.71% vs -2.44% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -8.72% vs -22.97% in Dec 2023

stock-summaryCompany CV
About Henry Schein, Inc. stock-summary
stock-summary
Henry Schein, Inc.
Retailing
Henry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The technology and value-added services segment provides software, technology and other value-added services to healthcare practitioners. Its technology group offerings include practice management software systems for dental and medical practitioners. The Company provides its services to dental practitioners and laboratories, and physician practices, as well as government and institutional healthcare clinics.
Company Coordinates stock-summary
Company Details
135 Duryea Rd , MELVILLE NY : 11747
stock-summary
Tel: 1 631 84355001 631 3908105
stock-summary
Registrar Details